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Previously it was shown that a 53-nucleotide viral replication origin, derived from the left-end (39) telomere of minute virus
of mice (MVM) DNA, directed integration of infecting MVM genomes into an Epstein–Barr virus (EBV)-based episome in cell
culture. Integration depended upon the presence, in the episome, of a functional origin sequence which could be nicked by
NS1, the viral initiator protein. Here we extend our studies to the genomic right-end (59) origin and report that three 131- to
135-nucleotide right-end origin sequences failed to target MVM episomal integration even though the same sequences were
functional in NS1-driven DNA replication assays in vitro. Additionally, we observed amplification of episomal DNA in response
to MVM infection in cell lines harboring episomes which directed integration, but not in cell lines containing episomes which
did not direct integration, including those with inserts of the MVM right-end origin. © 2001 Academic Press
left- anKey Words: MVM-targeted p220.2 episomal integration;
INTRODUCTION
Parvoviruses are small single-stranded DNA viruses
that infect a diverse range of organisms. Their linear
genomes terminate in small imperfect palindromes that
fold back on themselves to form complex hairpin telo-
meres which play a critical role in the modified form of
rolling-circle replication (RCR), dubbed “rolling-hairpin
replication,” employed by this virus family. Using its 39
hairpin as a primer for DNA synthesis, the linear parvo-
viral genome is amplified through a series of double-
stranded, monomeric, and concatemeric replicative in-
termediate DNA forms by a unidirectional, leading-
strand-specific fork. Resolution of these multimers into
unit-length genomes, and their further amplification, is
mediated by a virally coded initiator protein which re-
sembles other RCR initiators in having site- and strand-
specific nickase activity directed toward specific origin
sequences in the replicon (reviewed in Cotmore and
Tattersall, 1995).
Studies with adeno-associated virus 2 (AAV2), a
helper-dependent member of the Parvovirinae, have
shown that, in addition to its pleiotropic role in virus
replication, the AAV2 initiator protein Rep68/78 is respon-
sible for viral integration into a unique locus on human
chromosome 19q13-qter (reviewed in Kotin, 1994; Linden
et al., 1996b; Young et al., 2000). Chromosomal se-
quences which direct this site-specific integration event
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154d right-end origins.
have been analyzed using a model system in which
candidate sequences were inserted into the EBV-based
shuttle vector, p220.2, which could be propagated both in
bacteria and in mammalian cells as a stable episome.
Results from this in vivo model established that the
chromosomal target is a region containing a 16-nucleo-
tide Rep68/78 recognition sequence, similar to that in the
AAV2 origin, separated by a short spacer from a 6-nu-
cleotide sequence that closely resembles the nick site in
the viral origin cleaved by Rep68/78 (Giraud et al., 1994,
1995; Linden et al., 1996a; Meneses et al., 2000). This
chromosome 19 targeting element forms a complex with
Rep protein and AAV2 DNA in vitro (Weitzman et al., 1994)
and functions as a Rep-dependent origin in vitro (Urcelay
et al., 1995).
In contrast, the helper-independent MVM does not
appear to integrate into host chromosomes either during
productive infection (Richards and Armentrout, 1979) or
in persistently infected cell lines (Ron and Tal, 1985).
Unlike AAV2, MVM packages negative sense DNA pre-
dominantly and has unique hairpins at its left (39)- and
right-end (59) genomic telomeres, which differ from each
other in size, sequence, and potential secondary struc-
ture (Astell et al., 1985). The MVM initiator protein, NS1, is
able to recognize and nick both left- and right-end viral
origins, but initiation is more complex than that in AAV
because, in addition to the core NS1 recognition se-
quence and nick site, MVM origins contain essential
DNA sequences which allow the binding of auxilliary
cellular factors that differ at each telomere (Christensen
et al., 1997; Cotmore and Tattersall, 1998; Cotmore et al.,
2000).
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ATIONSince the presence of a functional origin appeared
necessary and sufficient to direct AAV2 integration into
p220.2 episomes in vivo, it seemed possible that MVM
origins might similarly direct episomal integration of in-
fecting MVM DNA. Indeed, when a minimal, 53-nucleo-
tide sequence from the MVM left-end origin was propa-
gated in p220.2 episomes in cell culture and the cells
were infected with MVM, integration was observed at
approximately the same frequency as had previously
been reported for AAV2 in the episomal model system
(Corsini et al., 1997). Mutational analysis of the MVM
origin sequences directing integration into the episome
revealed that modifications which inhibited NS1-medi-
ated nicking in an in vitro replication assay also impaired
pisomal integration in vivo, strongly suggesting that the
bility of NS1 to nick the episome was a prerequisite for
ntegration. These findings together with the analysis of
he recombinant structures (Corsini et al., 1997) lend
upport to the “copy-choice” model for site-specific inte-
ration which had emerged from the previous studies
ith AAV (Linden et al., 1996a). According to this model,
S1 positions the incoming viral genome at the episomal
ite, by binding to both structures. It then nicks the
pisomal origin and initiates unidirectional DNA synthe-
is, but the resulting fork occasionally switches between
emplates at downstream sites in the sequence, thus
inking the viral DNA to the episome.
Since the MVM genome contains two NS1-dependent
ick sites which have very different structures and re-
uire different cellular cofactors, we decided, in this
ollow-up study, to test whether the origin at the right end
f the genome could similarly target episomal integra-
ion. The results presented herein show that in contrast
o the left-end origin, the right-end origin failed to direct
pisomal integration even though it behaved as a func-
ional origin in DNA replication tests in vitro. In addition,
e report the observation that MVM infection induces
220.2 episomal DNA amplification in vivo when the
pisome carries an insert of the left-end origin. Such
ector DNA amplification was not observed when the
nserts were derived from the right-end origin. The impli-
ations of these observations for MVM integration in the
odel episome system, and the possible reasons for the
ontrasting activities of the left-end and right-end origin
NAs in that system, are discussed.
RESULTS
n contrast to episomes containing the left-end origin
NA, those containing right-end origin DNA do not
irect integration of infecting MVM DNA
For this study, we constructed six p220.2-based epi-
omes (Fig. 1) containing closely related versions of a
inimal right-end origin, characterized previously by Cot-
ore et al. (2000). Three of these episomes contained
MVM-TARGETED INTEGRequences that served as substrates for NS1-mediated
icking and DNA replication assays in vitro and three oere inactive in such reactions (see Materials and Meth-
ds). After subcloning the right-end origin DNA se-
uences into the p220.2 episomal shuttle vector, stable
93/C17 cell lines carrying individual episomes were
stablished. These cells were then infected with MVM,
nd genomic integration into the episome was assessed
y rescuing low-molecular-weight DNA from the cells
nd using it to transform Escherichia coli. The proportion
f rescued plasmids containing MVM DNA derived from
he infecting virus was then determined by colony hy-
ridization, as previously described (Corsini et al., 1997).
or comparison, we used cell lines carrying episomes
earing active and inactive MVM left-end origin se-
uences. Unexpectedly, the right-end origin sequences
id not direct significant levels of episomal integration
Table 1), while the left-end origin sequences directed
VM episomal integration at a frequency of 0.2–0.3%,
onsistent with previous observations (Corsini et al.,
997). This suggested that either episomes carrying min-
mal right-end origins could not be nicked in vivo or that
he presence of a functional nick site was not enough to
irect integration.
ubcloning of MVM right-end origin DNA in the EBV-
ased p220.2 shuttle vector does not alter its ability
o program DNA replication in vitro
FIG. 1. Diagram (not to scale) of the p220.2 shuttle vector containing
the MVM right-end origin insert R1-4AGA (MVM nucleotides 4911–
5046). A detailed description of R1–4AG is given under Materials and
Methods. The nick site (MVM nucleotides 4921–4927) and the AflIII site
(nucleotide position 4984) are shown to document the orientation of the
insert in the vector. hygr is the hygromycin phosphotransferase gene,
olE1 is the Escherichia coli origin of replication, ampr is the b-lacta-
ase gene conferring ampicillin resistance, and EBNA-1 and OriP are
he EBV genes required for episomal propagation of p220.2 (Yates et al.,
985).
155IN A MODEL SYSTEMThe minimal MVM left- and right-end origins were
riginally defined in vitro using replication assays pro-
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INI ETgrammed with the origin inserts in supercoiled pCRII
plasmids. In these assays, replication-competent S100
extracts from uninfected HeLa cells were supplemented
with purified histidine-tagged NS1 expressed in HeLa
cells from a recombinant vaccinia virus, and synthesis
was assessed by the incorporation of 32P-labeled dNTPs
nto high-molecular-weight DNA. Since the p220.2/right-
nd episomal constructs did not direct integration in vivo,
e first checked whether the EBV sequences in p220.2
oriP and EBNA-1; Yates et al., 1985) interfered with
icking in vitro using comparable assays. Although
220.2-based constructs carrying a standard MVM right-
nd origin are about twice as large as the corresponding
CRII construct (;9 and 4 kb, respectively), when
atched on a molar basis they both supported similar
evels of NS1-dependent DNA synthesis (Fig. 2A, cf.
anes 2 and 4), but supported little synthesis in the
bsence of NS1 (lanes 1 and 3). NS1 becomes covalently
ttached to the DNA during nicking and, accordingly, in
oth NS1-mediated reactions the replication products
ould be specifically immunoprecipitated with anti-NS1
erum (Fig. 2A, lanes 6 and 8), but not with preimmune
erum (Fig. 2A, lanes 5 and 7). We then compared a
election of other p220.2/right-end origin constructs with
heir pCRII counterparts, to ascertain whether the same
utations or deletions in the origin produced a similar
ffect on the replication of the two vectors. Of the con-
tructs shown in Fig. 2B, only the pCRII and p220.2 forms
f an origin sequence with a deleted nick site failed to
upport NS1-mediated replication (Fig. 2B, lanes 5 and
TABLE 1
Capacity of p220.2 Episomes, Carrying Different Inserts of MVM
Origin DNA, to Direct Integration of Infecting MVM DNAa
Cell line
MVM origin insert in p220.2
episome
MVM-positive
colonies (integration)
No./total %
7 Active left-end (p220.2/TC) 336/145,600 0.231
18 Active left-end (p220.2/wt oligo76) 72/29,000 0.248
8 Inactive left-end (p220.2/GAA) 8/134,000 0.006
31 Right-end R1-4AGA 7/185,600 0.004
32 Right-end R1-minAGA 0/176,800 ,0.001
33 Right-end R1-minAGA-1 0/128,000 ,0.001
34 Right-end R1-tv5-R4 2/152,000 0.001
35 Right-end R1-del5-R4 0/96,000 ,0.001
36 Right-end Rnickless-4AGA 0/96,000 ,0.001
a 293/C17 cell lines, stably propagating p220.2-based episomes with
he inserts of MVM origin DNA shown, were established and infected
ith MVM (20–40 PFU/cell); at 28 h postinfection, the episomes were
escued in Escherichia coli and integration was assessed by colony
ybridization with an MVM virion DNA probe as described (Corsini et
l., 1997). The p220.2-based episomes with the left-end origin DNA are
escribed in Corsini et al. (1997); those with the right-end origin DNA
re detailed under Materials and Methods and in Fig. 1.
156 CORS1, respectively), while the others all showed similar
evels of activity in the two vector environments. OnceFIG. 2. Comparison of pCRII- and p220.2-based right-end origin constructs
as substrates for NS1-mediated replication in vitro. (A) Replication and cova-
lent attachment of NS1 to products programmed by pCRII-based and p220.2-
based right-end origin constructs. Autoradiograph of an agarose gel showing
total replication products obtained using pR1-4AGA, a pCRII-based active
right-end origin construct, in the absence (lane 1) or the presence (lane 2) of
NS1, and the latter products immunoprecipitated with nonimmune serum (lane
5) or anti-NS1 serum (lane 6). Following linearization with ScaI, this material
gives a single major band which comigrates with linearized vector DNA (4.068
kb) plus multiple higher molecular weight species of uncertain structure, all of
which remain covalently associated with NS1. Total reaction products ob-
tained using pR1-4AGA subcloned in the p220.2 plasmid, in the absence (lane
3) or the presence (lane 4) of NS1, and the latter products following immuno-
precipitation with nonimmune serum (lane 7) or anti-NS1 serum (lane 8). When
digested with SspI, these products give a 9.067-kb linear fragment, as indi-
cated in the figure, plus additional minor species of a more complex structure
which is poorly understood at the present time. (B) Autoradiograph of an
agarose gel showing total linearized replication products generated using the
pCRII-based left-end or right-end origin DNA substrates (lanes 1–5) and
equivalent p220.2-based constructs (lanes 6–11). Two of the p220.2-based
right-end origin DNA constructs used in the assay (lanes 7 and 9) were
rescued from established cell lines prior to the analysis. Origin DNA inserts in
the constructs are as follows: L1-2TC, the minimum active origin sequence
from the left-end of the MVM genome (lanes 1 and 6); R1-4AGA (lanes 2 and
7); R1-minAGA (lanes 3, 8, and 9); R1-tv5-R4 (lanes 4 and 10); and Rnickless-
AL.4AGA (lanes 5 and 11). (C) Anti-NS1-immunoprecipitates of total replication
products shown in B.
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ted wiagain, immunoprecipitation experiments with an anti-
NS1-specific serum confirmed that these products were
initiated from an NS1-dependent replication fork (Fig.
2C). The experiments also showed that p220.2 con-
structs carrying MVM left- and right-end origins directed
similar levels of NS1-mediated replication in vitro (Figs.
B and 2C, compare lane 6 with lanes 7–9). Thus, the
BV sequences in p220.2 did not appear to hamper
S1-mediated nicking reactions in vitro.
Since the above assays were carried out with the
220.2-based constructs prior to their propagation as
table episomes in cell culture, we next considered the
ossibility that the repetitive sequence of the right-end
rigin might make it susceptible to rearrangement when
ropagated as a circular episome in vivo. To address this
ossibility, a selection of p220.2/right-end origin shuttle
ectors were rescued from parallel passages of stable
uninfected) 293/C17 cell lines and used to transform E.
coli. The MVM origin inserts in these rescued plasmids
were first sequenced (data not shown) and then tested in
vitro for their ability to support NS1-dependent nicking
and replication (Figs. 2B and 2C, lanes 7 and 9). Such
FIG. 3. MVM infection induces p220.2-specific DNA amplification wh
ontains right-end origin DNA. (A) Cells carrying p220.2 episomes
p220.2/TC) (lanes 5–8) were infected with MVM (lanes 3, 4, 7, 8) or mo
he extrachromosomal DNA was extracted by the Hirt procedure (Hirt,
outhern blotting (32P-p220.2 DNA probe). The DNA size markers on
espectively, of the supercoiled and nicked/relaxed p220.2 episomes. O
gainst the same 32P-labeled p220.2 DNA probe. The lower portion sho
PSL/mm2; average of duplicate dot blots). (B) Cells carrying episomes
2) or the right-end origin DNAs shown in Table 1 (lanes 3–8) were infec
3–8 was 1/5th the yield of 9,000,000 cells.
MVM-TARGETED INTEGRrescued plasmids were as active in the in vitro assays as
those that had not been propagated as stable episomes.MVM infection induces episomal DNA amplification
when episomes contain left-end origin DNA but not
when the episomes contain right-end origin DNA
We next turned our attention to the possibility that
although the right-end origin sequences in p220.2 shuttle
vectors, either before or after propagation as episomes,
were able to direct NS1-mediated DNA replication in
vitro, they might not be functional in vivo. To explore
possible systems for assessing functionality, we first
analyzed low-molecular-weight DNA extracted from cell
lines carrying episomes with active or inactive left-end
origins. Figure 3A shows data from an experiment in
which extrachromosomal DNA was extracted at two dif-
ferent time points from infected and mock-infected cell
lines and analyzed by Southern blot and dot blot hybrid-
ization using a probe specific for p220.2 sequences.
Vector-specific DNA amplification was readily apparent
in Southern blots of infected cells carrying episomes
with active left-end origin inserts (Fig. 3A, lanes 7 and 8),
where it gives rise to several discrete bands and a
heterogeneous “smear” of DNA spanning the entire
episome contains MVM left-end origin DNA but not when the episome
ft-end origin inactive DNA (p220.2/GAA) (lanes 1–4) or active DNA
cted (lanes 1, 2, 5, 6). At 16 h (lanes 1, 3, 5, 7) or 27 h (lanes 2, 4, 6, 8)
Ten microliters (1/5th of the yield of 3,000,000 cells) was analyzed by
ght are in kbp. Co. I and Co. II, on the left, designate the positions,
oliter (1/50th) of each extract was also analyzed by dot blots hybridized
autoradiograms of duplicate dot blots and the phosphorimager scans
e active left-end origin DNAs (p220.2/TC, lane 1; p220.2/oligo76, lane
th MVM and analyzed as above except that the input per well in lanes
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ATIONlength of the gel. In contrast, episomes containing the
inactive left-end origin did not amplify their DNA during
a
M
s
g
3
w
2
m
p
s
F
m
n
b
m
c
c
H
m
b
a
m
n
a
e
t
m
(
t
m
c
M
s
s
o
i
o
i
t
l
s
e
o
e
d
e
(
c
t
w
n
a
T
s
o
r
s
1
t
m
d
f
s
M
a
p
a
s
f
1 INI ETMVM infection (Fig. 3A, compare lanes 3 and 4). Addi-
tional mutations in the left-end origin sequence which
abrogated nicking in vitro also abrogated episomal DNA
mplification and targeted integration in response to
VM infection (data not shown), suggesting that in this
ystem episomal DNA amplification accompanies inte-
ration. The dot blot analysis in the bottom panel of Fig.
A indicates that in cell lines propagating episomes
hich target integration, total p220.2-specific DNA at
7 h postinfection was amplified 18-fold relative to the
ock-infected controls (compare lanes 6 and 8, bottom
anel).
At present we do not know the structure of the p220.2-
pecific amplification products. The patterns shown in
ig. 3A, lane 8, and Fig. 3B, lane 1, indicate a complex
ixture. Several distinct bands as well as a heteroge-
ous smear of products can be discerned. There is a
and at the position of the nicked, relaxed form II episo-
al DNA (labeled Co. II in the figure) which is signifi-
antly amplified compared to the controls, perhaps indi-
ating an accumulation of nicked unit-length episomes.
owever, there is also a broad band of p220.2-specific
aterial stretching down from this position toward and
eyond the 9.4-kbp molecular weight marker, and there
re amplified p220.2-specific DNA forms with reduced
obilities extending up to the sample well of the gel. Two
ew high-mobility species, of around 1.5 and 1.7 kbp,
ppeared in the extracts of the infected cells carrying
pisomes with active left-end origins but not in the con-
rols (see arrows in Figs. 3A and 3B). The remaining
ajor band, at the position of supercoiled episomal DNA
labeled Co. I) was not detectably amplified in response
o infection, suggesting that only a small fraction of the
olecules in the episomal pool underwent the amplifi-
ation process.
We then proceeded to examine episomes bearing
VM right-end origin sequences. In contrast to the re-
ults with active left-end origin inserts, none of the epi-
omes with right-end origin inserts showed any evidence
f p220.2-specific DNA amplification in response to viral
nfection (Fig. 3B, lanes 3–8). To optimize the possibility
f seeing new DNA species, three times more MVM-
nfected cells were used for preparing these extracts
han for the left-end origin positive controls (Fig. 3B,
anes 1 and 2), which accounts for the increased inten-
ity of the band migrating at the position of supercoiled
pisomes (Co.I) in lanes 3–8. The characteristic features
f amplification described for episomes with active left-
nd origin inserts were absent from these samples, and
ot blot quantitation showed that there were higher lev-
ls of total p220.2-specific DNA in the positive controls
Fig. 3B, bottom panel, lanes 1 and 2) even though fewer
ells were analyzed in these samples. Thus, it appears
hat the minimal sequence from the MVM right-end origin
hich can serve as an NS1-dependent origin in vitro is
58 CORSot able to function as such when propagated as part of
n p220.2-based episome in vivo. This is in striking
t
tcontrast to episomes bearing inserts of left-end origin
DNA, where in vitro activity corresponds with intracellu-
lar episomal DNA amplification in response to MVM
infection.
MVM DNA replicates in 293/C17 cells irrespective of
the type of episome they carry
Previously we had noted that 293/C17 cells undergo a
cytopathic effect at 30 h postinfection and supported a
degree of MVM DNA amplification (Corsini et al., 1997).
o determine if these cell lines differed in their ability to
upport MVM DNA replication, depending upon the type
f episome they harbor, the blot shown in Fig. 3A was
ehybridized with an MVM virion DNA probe (after a
uitable period for decay of the previous probe). Between
6 and 27 h postinfection there is substantial amplifica-
ion of MVM DNA (Fig. 4, lanes 3, 4, 7, and 8). The two
ajor MVM-specific bands observed appear to be the
ouble-stranded monomeric and dimeric replicative
orms, as judged by their mobilities. No discrete DNA
pecies with the mobility expected of single-stranded
VM DNA was observed, suggesting that 293/C17 cells
re only semipermissive and that progeny virions are not
roduced. This is consistent with a previous report that
FIG. 4. 293/C17 cells carrying episomes with either active or inactive
left-end MVM origin DNA support replication of infecting MVM DNA.
The Southern blot in Fig. 3A (after a suitable period for radioactive
decay) was rehybridized with 32P-labeled MVM virion DNA. Lanes 1–8
re described in Fig. 3A. Single and double arrowheads denote, re-
pectively, the monomeric and dimeric double-stranded replicative
orms of MVM DNA.
AL.he progenitor 293 cell line supports MVM DNA replica-
ion without generating significant levels of progeny viri-
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ATIONons (Fox et al., 1990). Importantly, it will be noted that the
pattern of MVM-specific DNA replication (Fig. 4, lanes 7
and 8) in Cell Line 7 which carries an active episome that
directs MVM episomal integration (Table 1) is very sim-
ilar to that of Cell Line 8 (Fig. 4, lanes 3 and 4), whose
episomes do not direct integration of the infecting virus
DNA (Table 1). Overexposure of the Southern blot in Fig.
4 revealed only slightly different banding patterns con-
fined to the low-mobility MVM DNA species located in
the sample well and between the sample well and the
position of the 9.4-kbp marker. To what extent these
differences reflect the presence of recombinant p220.2/
MVM species was not determined, but the efficiency with
which such forms were recovered by marker rescue in E.
coli was low (Table 1), suggesting that they may be rare.
The blot shown in Fig. 3B was also rehybridized with an
MVM virion DNA probe. Cell lines carrying p220.2-based
episomes with right-end origins (lanes 3–8) were as
permissive for MVM DNA replication as those carrying
episomes with the left-end origins (lanes 1 and 2). The
phosphorimager scans of the MVM-specific monomeric
RF species (the predominant band) gave values of 58.6–
97.7 PSL/mm2 for lanes 3–8 and values of 12.6 and 52.0
SL/mm2 for lanes 1 and 2, respectively. In general, the
evel of infecting MVM DNA replication and the RF spe-
ies were similar in the different 293/C17 cell lines,
rrespective of the targeting capacity of the episomes
hey carry.
DISCUSSION
In this communication, which extends a previous study
f MVM integration in a model episomal system (Corsini
t al., 1997), we document two new observations. Cell
ines propagating episomes with inserts of MVM origin
NA which direct integration of an infecting MVM ge-
ome also support episomal DNA amplification in re-
ponse to that infection, and the minimal left-end and
ight-end MVM origins, as defined by DNA replication
ssays in vitro, differ in their capacity to direct episomal
NA amplification and integration in vivo.
The 293/C17 cell lines propagating stable EBV-based
p220.2 episomes contain, on average, 50–100 molecules
of the episome per cell (reviewed in Margolskee, 1992).
The connection between episomal amplification and in-
tegration in response to exogenous MVM infection must
first be viewed in the context that these events occur in
only a minor fraction of the episomal population. As
judged by rescue in E. coli, only around 0.2% of the
episomes acquired MVM genomic DNA by integration,
although this value may be somewhat of an underesti-
mate in view of the selective nature of the assay, which
detects mainly integrants that have preserved the mark-
ers and structure required for efficient rescue in E. coli
(Giraud et al., 1995). The proportion of episomes under-
MVM-TARGETED INTEGRgoing DNA amplification is also unlikely to be high since
the fraction of episomal molecules isolated as super-
e
rcoiled DNA appeared to be similar to that isolated from
the uninfected controls (Fig. 3A). Hence, we do not know
if the subpopulation of episomes which serves as a
substrate for integration is the same as the subpopula-
tion which undergoes DNA amplification. Nevertheless,
the mutational analysis of the MVM left-end origin insert
in p220.2 episomes has revealed striking correlations in
that mutations which abrogated origin activity in in vitro
assays abrogated both episomal DNA amplification and
episomal integration in infected cell lines.
If targeted MVM integration occurs in the same epi-
somal subpopulation as that which undergoes the DNA
amplification described in Fig. 3A, then a unique mech-
anism for MVM integration, distinct from the “copy-
choice” model proposed originally for AAV, can be con-
sidered. Since replicating MVM RF molecules and a
heterogenous collection of episomes undergoing aber-
rant DNA amplification are present in the same cell, it
seems possible that DNA ligases could randomly join
nicked episomal DNA to MVM RF DNA, without having to
propose the template switching event inherent in the
“copy-choice” model. Ligation of MVM RF species is
recognized as a stage in the MVM replication pathway
and has been detected in in vitro experiments (Baldauf et
al., 1997). In addition, recent studies with the AAV initiator
protein Rep 78 indicate that this protein may be able to
carry out both nicking and joining reactions on single-
stranded DNA, cleaving the DNA on the 59 side of thy-
midine residues and linking it to the 39 side of another
ingle-stranded oligonucleotide (Smith and Kotin, 2000).
he possibility that Rep 78 may mediate integration by
trand cleavage and exchange between an AAV replica-
ion intermediate and the chromosome 19 target has
een raised by these authors. If NS1 were able to pro-
ote similar joining events, the abundant presence of
S1 protein and nicked DNA substrates (of MVM and
pisomal origin) in the same cell could provide a suitable
nvironment for reactions of this type. The “copy-choice”
emplate-switching model for site-specific AAV or MVM
ntegration and the ligase-mediated joining model dis-
ussed above are not mutually exclusive since we can
nvisage both reactions occurring as primary and sec-
ndary events in the same recombination pathway. How-
ver, in terms of a primary event, the recombinant struc-
ure would be expected to differ in these models. “Copy-
hoice” integration would position the MVM genomic
nsert downstream of the point where DNA synthesis
nitiated (that is, exclusively on one side of the nick),
hereas ligase-mediated ligation would not be expected
o be subject to the same constraint. Further work on the
tructure of the p220.2/MVM recombinants may resolve
his issue.
The second finding reported here is that only one of
he two minimal MVM origins, defined in vitro, functions
s an NS1-dependent origin in the context of the p220.2
159IN A MODEL SYSTEMpisome in vivo. Meneses et al. (2000) have recently
eported a minimal sequence that is required for integra-
INI ETtion of AAV into its chromosomal target (known as
AAVS1) using the episome system as a model. They also
noted that one of their mutant test origins failed to direct
integration despite the fact that it was nicked in vitro, but
it is not known whether that particular mutant AAVS1
sequence in the episome was nicked in vivo. Nonethe-
less, it does illustrate that, as with the MVM minimal
right-end origin, the ability to be nicked in vitro does not
necessarily correlate with the ability to direct integration
in vivo.
We have considered several explanations for the lack
of correspondence between the in vitro and in vivo as-
sessments of the MVM right-end origin activities. One is
that elements in the p220.2 episome, such as the EBV-
derived oriP and EBNA-1 gene, may interfere in vivo with
the functioning of the right-end origin DNA but not with
the left-end origin. The 293/C17 cells used to propagate
p220.2-based episomes produce EBNA-1 constitutively
(Canfield et al., 1990) and putative EBNA-1 DNA binding
motifs have been reported to be present at the right end
of the MVM genome (Tenenbaum et al., 1993). Hence,
binding of EBNA-1 to the MVM right-end origin DNA
might interfere with the activity of that origin in vivo.
However, the EBNA-1 DNA binding motifs described by
Tenenbaum et al. (1993) are not present in the MVM
right-end origin DNA inserted into p220.2; in addition,
these right-end origin inserts do not contain the se-
quence motifs described by Yates et al. (2000) as con-
stituting the minimal canonical EBNA-1 binding site in
oriP. Thus, although we do not exclude some type of
interference between oriP and the functioning of the
MVM right-end origin in the same episome in vivo, it
appears unlikely that EBNA-1 is involved.
An alternative explanation for the difference between
the in vitro and in vivo assessments of MVM right-end
origin DNA is that in the cell, p220.2-based episomes are
coated with components of cellular chromatin (Jenkins et
al., 2000; J. L. Yates, personal communication), whereas
all in vitro assays are carried out with naked DNA sub-
strates. Before discussing how chromatin structure
might differentially control the contrasting activities of
the right- and left-end MVM origins in the episomal
setting, it is important to note that, in the context of the
linear MVM genome, origin activity is unlikely to be
constrained in the same way. Replicating MVM DNA
does exist as a nucleoprotein complex, but the protein
constituents of this chromatin have yet to be identified,
and it is clearly organized very differently than that of
cellular DNA (Doerig et al., 1986). In addition, since NS1
is expressed to very high levels in MVM-infected cells,
and NS1 binding sites of unknown function are liberally
dispersed throughout the viral genome (Cotmore et al.,
1995) speculation has arisen that NS1 bound to replica-
tive intermediates might take over the role of some com-
ponents of cellular chromatin (Cotmore and Tattersall,
160 CORS1998). The differences between viral and episomal, cel-
lular-like, chromatin structure mean that, at present, weare uncertain that our in vivo observations of origin
activity in the context of the EBV p220.2-based episome
can be extrapolated to the replicating MVM genome.
When exploring the potential for viral integration into
cellular DNA, the presence of cellular chromatin in the
p220.2-based episome makes it a valid model target. The
access of site-specific DNA binding proteins to chroma-
tin-packaged DNA involves highly regulated changes in
nucleosomal structure, mediated by ATP-dependent
chromatin remodeling complexes and other enzymatic
complexes which control histone acetylation and
deacetylation (reviewed in Aalfs and Kingston, 2000).
There are several ways in which this type of regulation
could differentially control access of NS1 to the minimal
MVM left- and right-end origins. For example, the cellular
cofactor for the left-end origin, parvovirus initiation factor
(PIF) interacts with a CREB binding protein (Kaul et al.,
2000) that has intrinsic histone acetyltransferase activity
and mediates the activity of several transcription factors
(Chen et al., 2001). In contrast, the cellular cofactor for
the right-end origin is a member of the HMG1 family
(Cotmore and Tattersall, 1998), a major structural com-
ponent of chromatin, which binds with high affinity to
sharply bent DNA at the entry and exit of nucleosomes
(reviewed in Wolffe, 1999; Calogero et al., 1999) but which
is not known to be involved in modulating histone acet-
ylation. Thus the binding of PIF to the left-end origin in
the episomal insert could result in a level of histone
acetylation that provides NS1 with access to episomal
DNA. In contrast, an analogous mechanism facilitating
NS1 access to episomal DNA with inserts of the right-
end origin may be lacking.
An additional possibility could be that the presence of
cellular histones coating the episome does not specifi-
cally block entry of NS1, but rather constrains the ability
of the MVM right-end origin insert to undergo structural
changes necessary for its activation. In the 50-bp mini-
mal left-end origin, the interaction between the cellular
cofactor PIF and NS1 is mediated by the DNA binding
domain of the PIF p79 subunit. This subunit must bind to
the origin at a precise distance (six nucleotides) from the
NS1 binding site in order to establish an interaction with
NS1 which activates its nickase function (Christensen et
al., 2001; Christensen, Ticknor, Burnett, Cotmore, and
Tattersall, in preparation). Thus activation of NS1 at this
origin is a highly localized event, which does not appear
to involve refolding large regions of DNA. In contrast, the
minimal right-end origin is around 132 bp and contains
two critical NS1 binding sites, one oriented next to the
nick site in such a way that its DNaseI footprint extends
over the nick site and a second positioned in the same
orientation but some 120 bp away. NS1 can only nick this
origin with the help of HMG1, the sequence-nonspecific
DNA bending protein, which interacts with, and coordi-
nates, the two widely spaced NS1 complexes (Cotmore
AL.et al., 2000). The NS1 complexes, in turn, appear to
anchor and focus the HMG-induced bend, so that a
a
l
R
c
s
i
d
R
T
l
r
o
s
w
l
(
I
p
v
N
t
c
l
c
e
p
g
t
r
D
ATIONdouble helical loop is generated at a specific site in the
intervening DNA sequence. All active mutant right-end
origins adopt this precise three-dimensional configura-
tion, while inactive mutants often do not, suggesting that
the structure is necessary for initiation at this origin
(Cotmore and Tattersall, unpublished data). Such neces-
sary distortions of the right-end origin sequence embed-
ded in a circular 9-kbp episome, coated with cellular
chromatin, may be difficult to achieve.
In addition to the above specific role of HMG1 in
refolding the MVM right-end telomere to bring into play
two critical, but widely spaced NS1 binding sites, HMG1
may also have a more general activity in promoting the
assembly of parvovirus initiator protein complexes. For
example, HMG1 physically interacts with the AAV2
Rep68/78 initiator protein, enhancing the nicking and
hydrolysis of ATP functions in vitro as well as the repres-
sion of the viral P5 promotor in transfected cells (Costello
et al., 1997). Interestingly, a recent report suggests that
HMG1 enhances recombination between AAV2 DNA and
p220.2/AAVS1 DNA in cell-free reactions (Dyall et al.,
1999).
Finally, it is possible that at the right end of the MVM
genome there may be sequences which serve the same
role as the V(D)J enhancer elements that control access
of the site-specific RAG recombinase enzyme, a regu-
lated access that may depend upon histone acetylation
(McMurry and Krangel, 2000). These could permit the
entry of cellular factors capable of disrupting the chro-
matin, but they would not be required for the activation of
naked DNA in vitro and so would not be included in the
minimal right-end origin constructs. Using transient co-
transfections of an NS1-expressing construct and a plas-
mid containing MVM minigenomes lacking various inter-
nal segments, Astell and co-workers explored the viral
DNA sequences required in cis for replication (Tam and
Astell, 1993; Brunstein and Astell, 1997). These authors
reported a requirement for cis-acting DNA sequences
located inboard of the 59 hairpin, within a region bor-
dered by MVM nucleotides 4489–4695, which is not
present in the minimal right-end origin analyzed here.
Recent studies with recombinant H1 parvoviruses have
also shown that cis-acting sequences located in the
capsid gene may be required for efficient DNA replica-
tion in vivo (Kestler et al., 1999). Further work will thus be
required to assess the relative contribution of DNA in-
board of the MVM telomeres to both the left- and right-
end origins when they are in the episomal setting.
MATERIALS AND METHODS
Plasmids
p220.2-based episomes carrying MVM right-end origin
DNAs were prepared by excising inserts from pCRII/
MVM constructs (previously described in Cotmore et al.,
MVM-TARGETED INTEGR2000), cutting in the vector polylinker with HindIII and
XbaI, and recloning them between the same sites inp220.2 (Fig. 1). The “standard” origin insert (R1-4AGA)
contains the MVM sequence 59 aga cta ctg tct att cag tga
acc aac tga acc att agt att act atg ttt tta ggg tgg gag ggt
ggG AGA Tac atg tgt tcg cta tga gcg aac tgg tac tgg ttg
gtt gct ctg ctc aac caa cca gac cgg c 39 (MVM nucleo-
tides 4911–5046). In this sequence, the nick site is un-
derlined, the critical NS1 binding sites (Cotmore et al.,
2000) are highlighted in bold, and the capitals denote a
5-base sequence next to the single AflIII site (at nucle-
otide position 4984) which is mutated in some clones.
The minimal active origin (R1-minAGA) is similar, but
lacks 4 bases from the 39 end of the sequence shown
bove, while the inactive origin sequence, R1-minAGA-1,
acks 1 additional base from the 39 end of the insert.
1-tv5-R4 contains the full sequence shown above ex-
ept that transversions, 59 TCT CG 39, replace the 5-base
equence 59 GAG AT 39 positioned next to the AflIII site
n the original. This insert serves as an active NS1-
ependent origin when assayed in vitro, while R1-del5-
4, which has these same 5 bases deleted, is inactive.
he final construct, Rnickless-4AGA, has 17 bases de-
eted from the 59 end of the sequence shown, which
emoves the consensus nick site and inactivates the
rigin.
Plasmids p220.2/TC and p220.2/WToligo76 are epi-
omes carrying active forms of the MVM left-end origin,
hile p220.2/GAA harbors an inactive version of the
eft-end origin. All three have been described previously
Corsini et al., 1997).
n vitro replication assays
Recombinant histidine-tagged MVM NS1 was ex-
ressed in HeLa cells by co-infection with vaccinia virus
TF7-3 (which expresses T7 polymerase) and vv-his-
S1wt (which expresses full-length copies of NS1 from
he T7 promoter). NS1 was purified by nickel-chelate
hromatography as described (Nu¨esch et al., 1998). Rep-
ication extracts were prepared from uninfected HeLa
ells essentially as described by Wobbe et al. (1985),
xcept that they were dialyzed against 20 mM Tris–HCl,
H 7.5, 0.2 mM EDTA, 25 mM NaCl, 0.5 mM DTT, 10%
lycerol, and 20% sucrose, which concentrated the ex-
racts approximately fourfold. Assays (20 ml) contained
ecombinant vaccinia NS1 (10 mg/ml), deoxynucleotides,
MgCl2, ATP and an ATP-regenerating system, template
NA (5 mg/ml), and a 32P-labeled dNTP and were termi-
nated and analyzed as previously described (Cotmore et
al., 1992).
Cells
The C17 derivative of the 293 cell line expresses the
EBV EBNA-1 gene constitutively (Canfield et al., 1990).
Transactivation of the EBV OriP origin in p220.2 by
EBNA-1 is required for stable episome propagation in
161IN A MODEL SYSTEMcultured cells (reviewed in Margolskee, 1992; Yates et al.,
2000). 293/C17 cells were propagated in Dulbecco’s
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INI ETmodified Eagle’s medium with 10% fetal bovine serum
and G418 at 600 mg/ml. The purpose of the latter was to
nsure maintenance of the chromosomally located EBV
BNA-1 gene whose expression (in addition to that of the
BNA-1 gene carried in p220.2) enhances the stability of
pisome propagation. Cell lines propagating the p220.2
pisomes, and episomes with inserts of MVM origin
NA (Fig. 1), were generated by transfecting the appro-
riate constructs into 293/C17 cells and selecting for
ygromycin resistance (minimum of five culture pas-
ages split 1:5 in the presence of 200 mg/ml of hygromy-
cin B) as described in Corsini et al. (1997).
Infection and isolation of episomal DNA
Cell lines at 60–90% confluency were infected with
MVMp at 20–40 PFU/cell. After virus adsorption for 1 h at
37°C, the inoculum was removed and replaced with the
original culture medium. At 28 h postinfection (before the
onset of a severe MVM cytopathic effect) extrachromo-
somal episomal DNA was extracted by the Hirt (1967)
procedure and purified by three sequential alcohol pre-
cipitations, as described in Giraud et al. (1994). The
episomal DNA yields from 3 3 106 to 9 3 106 cells were
suspended in 25–50 ml of TE.
Analysis of episomal DNA
Each episomal DNA yield was analyzed as follows. (A)
To assess MVM integration, 3 ml was electroporated into
the SURE (Stratogene) strain of E. coli and ampicillin-
resistent p220.2 colonies containing inserts of MVM
genomic DNA were identified by colony hybridization
with a MVM DNA probe, prepared using the “rediprime
random primer” kit (Amersham International) [a-32P]dCTP
nd single-stranded DNA from purified virions as the
ubstrate. The frequency of integration is given by the
roportion of total rescued ampicillin-resistant colonies
hich contain MVM DNA (see Corsini et al., 1997, for
etails of this assay). (B) To investigate episomal DNA
mplification, 10 ml was electrophorised in 1% agarose
els, blotted to Hybond N (Amersham Life Science) by
he Southern procedure (Southern, 1975), and hybridized
ith a p220.2 (empty vector) DNA probe. Episomal DNA
mplification was also assessed by 1 ml dot blots, hy-
bridized with the labeled p220.2 DNA probe. Southern
and dot blots were rehybridized with a MVM virion DNA
probe to assess MVM DNA replication in 293/C17 cells.
Hybridization conditions were as described in Corsini et
al. (1997) and hybridization signals were quantitated by
phosphorimager analysis.
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